A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis

Rhinology

Volumn 38, Issue 4, 2000, Pages 185-190

  Filiaci, F ^a   Passali, D ^a   Puxeddu, R ^a   Schrewelius, C ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Budesonide; Glucocorticosteroids; Magnetic resonance imaging; Nasal polyposis Turbuhaler

Indexed keywords

BUDESONIDE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; INHALER; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NASAL POLYPS; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 0034533385     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Dry powder inhalation of budesonide in allergic rhinitis
2. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis
3. Histopathologic examinations of nasal polyps of different etiology
4. Intranasal budesonide aqueous pump spray (Rhinocort Aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study Group
5. The release of histamine from nasal polyp tissue and peripheral blood when challenged with anti-human IgE, house dust mite extract and mixed grass pollen extract and compared with positive skin tests
6. The effect of prescribed daily dose frequency on patient medication compliance
7. Budesonide nasal spray as prophylactic treatment after polypectomy-A double-blind clinical trial
8. Clinical Performance of fluticasone propionate nasal drops
9. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis
10. Once-daily dose of budesonide aqueous nasal spray 128 g is efficacious primary treatment with rapid onset in nasal polyps
11. The effect of budesonide (Rhinocort®) in the treatment of small and medium-sized nasal polyps
12. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment
13. Efficacy of topical corticosteroid powder for nasal polyps: A double-blind, placebo-controlled study of budesonide
14. Effect of fluticasone in severe polyposis
15. Clinical and antiinflammatory effects of intranasal budesonide aqueous pump spray in the treatment of perennial allergic rhinitis
16. Reversible fatty acid conjugation of budesonide. Novel mechanism for prolonged retention of topically applied steroid in airway tissue
17. Nasal polyps
18. Fatty acid ester formation appears to increase and prolong the retention of budesonide in human nasal mucosa in vivo as compared with fluticasone propionate
19. Position statement of nasal polyps
20. A double-blind comparison of intranasal budesonide with placebo for nasal polyposis
21. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps
22. Inflammatory cells in asthma and rhinitis
23. Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line in vitro